A New Category vs. the Established Standard
The knee osteoarthritis treatment landscape is evolving. Arthrosamid represents an entirely new approach: a permanent, non-biodegradable hydrogel that integrates into the joint lining. Gel injections (hyaluronic acid viscosupplementation) have been the standard non-surgical knee OA treatment for over 25 years.
These are not just different products. They are different categories of treatment with fundamentally different mechanisms. Here is what you need to know in 2026.
Quick Comparison Table
| Feature | Arthrosamid | Gel Injections (HA) |
|---|---|---|
| Type | Polyacrylamide hydrogel | Hyaluronic acid |
| How it works | Integrates into joint lining | Lubricates joint fluid |
| Injections needed | 1 | 1-5 per course (brand dependent) |
| Duration of relief | 2-3+ years (early data) | 6-12 months |
| Biodegradable | No (permanent) | Yes (absorbed by body) |
| FDA approved (US) | No | Yes (7+ brands) |
| Medicare covered | No | Yes |
| Self-pay cost | $3,000-$5,000 | $400-$1,500 |
| With insurance cost | $3,000-$5,000 (not covered) | $100-$300 |
| Available in US | Clinical trials only | Every orthopedic practice |
| Allergy concerns | None (synthetic) | Some brands avian-derived |
| Safety data | ~10 years | 25+ years |
| Brands available | Arthrosamid only | Synvisc-One, Monovisc, Euflexxa, Durolane, Gel-One, Hyalgan, Supartz, Orthovisc |
How Gel Injections Work (The Established Approach)
Hyaluronic acid gel injections supplement the natural lubricating fluid in your knee joint. In a healthy knee, synovial fluid contains high concentrations of HA that provide lubrication and shock absorption. Osteoarthritis depletes this fluid, making joints stiff and painful.
Gel injections temporarily restore what OA takes away:
- HA is injected directly into the joint space
- Immediately begins lubricating and cushioning
- Full benefit develops over 4-6 weeks
- Gradually broken down by the body over months
- Treatment repeated every 6 months for continued benefit
There are 7+ FDA-approved HA brands in the US, ranging from single-injection products (Synvisc-One, Monovisc, Durolane, Gel-One) to multi-injection series (Euflexxa, Supartz, Hyalgan, Orthovisc).
Why Gel Injections Are the Current Standard
- 25+ years of FDA-approved use with extensive safety data
- Covered by Medicare Part B and most private insurance
- Widely available at orthopedic and pain management clinics nationwide
- Multiple brand options allow customization based on allergies, schedule, and cost
- Fully reversible — if a product does not work, it is absorbed naturally and does not affect future options
- Evidence base includes hundreds of clinical trials and real-world studies
How Arthrosamid Works (The New Approach)
Arthrosamid is a 2.5% polyacrylamide hydrogel (97.5% water) that works completely differently from any HA product:
- Single injection into the knee joint
- Migrates to the synovial membrane (joint lining) within weeks
- Integrates into the tissue — becomes part of the joint lining
- Does not biodegrade — the hydrogel remains permanently
- Restores thickness and elasticity of the joint capsule
- Provides long-term cushioning without repeated treatment
The Promise
If Arthrosamid’s early results hold up in larger trials, patients could receive a single injection and not need retreatment for 2-3+ years. For a patient currently getting HA injections twice a year, that means replacing 4-6 treatment series with one injection.
The Limitations (As of 2026)
Cost: The Practical Reality
For most American patients, cost alone makes this comparison straightforward:
| Scenario | Arthrosamid | Gel Injections |
|---|---|---|
| Single treatment | $3,000-$5,000 | $100-$300 (with insurance) |
| Annual cost | $1,000-$2,500/year (amortized over 2-3 years) | $200-$600/year |
| 3-year cost | $3,000-$5,000 | $600-$1,800 |
| Insurance coverage | None | Yes (Medicare + most private) |
Even amortized over its potentially longer duration, Arthrosamid costs more than gel injections when insurance is factored in. The math only favors Arthrosamid for self-pay patients who respond well to the treatment and it truly lasts 3+ years.
Who Should Stick with Gel Injections?
The vast majority of knee OA patients in 2026 should continue with gel injections because:
- They are proven effective with decades of evidence
- They are affordable with insurance coverage
- They are available at your local doctor’s office
- They are reversible — no permanent changes to your joint
- There are 8+ brand options to try if one does not work
- They have a well-understood safety profile
Who Might Consider Arthrosamid?
A very small subset of patients may reasonably explore Arthrosamid:
- Those who have tried multiple HA brands without adequate relief
- Patients who can afford $3,000-$5,000 out of pocket
- Those willing to travel internationally for treatment
- Patients who understand and accept the risks of an emerging treatment
- People who are enrolled in a US clinical trial
Frequently Asked Questions
When will Arthrosamid be available in the US?
As of 2026, Arthrosamid is undergoing the FDA approval process. Timeline is uncertain, but it could take several years. Check with your doctor for the latest developments.
Can I get Arthrosamid after gel injections?
Yes. HA injections are fully biodegradable and do not interfere with future Arthrosamid treatment.
Is Arthrosamid a gel injection?
No. Despite being injected into the knee, Arthrosamid is a fundamentally different type of treatment. It is a polyacrylamide hydrogel that permanently integrates into the joint lining, while gel injections (HA) temporarily supplement the joint fluid.
Should I wait for Arthrosamid instead of getting gel injections?
No. Gel injections are available, proven, and affordable right now. There is no reason to suffer with untreated knee pain waiting for an unproven treatment that may take years to reach the US market.
The Bottom Line
Proven Now vs. Promising Later
Gel injections remain the clear winner for American patients in 2026. They are FDA-approved, insurance-covered, widely available, backed by 25+ years of data, and effective for the majority of knee OA patients. With 8+ brands to choose from, there is an HA product for virtually every patient profile.
Arthrosamid is a genuinely promising innovation that may one day change the treatment landscape. But until it has FDA approval, insurance coverage, US availability, and long-term safety data, it is not a practical option for most people.
Our advice: Get the relief you need now with proven gel injections. Watch the Arthrosamid developments with interest, but do not delay treatment waiting for it.
Find Gel Injection Specialists
Connect with providers offering proven HA injection treatments for knee osteoarthritis.
Your information is secure. See our Privacy Policy and Terms of Service.
Thank You!
We've received your request. A provider specialist will contact you within 1-2 business days to help you find the right care.
What happens next?
- 1 We'll verify your insurance coverage
- 2 Match you with quality providers in your area
- 3 Contact you to discuss your options
Questions? Browse our guides:
How to Choose a ProviderRelated Comparisons
- Arthrosamid vs. Synvisc
- Cortisone vs. Gel Injections
- PRP vs. HA Injections
- Gel Injections vs. Knee Replacement
- Stem Cell vs. HA Injections
Stay Updated on Knee OA Treatments
Get the latest on emerging treatments and proven options for knee osteoarthritis.
Join 10,000+ readers. No spam.